TL;DR: The Centers for Medicare & Medicaid Services modified NCD 268, its prostate cancer screening coverage policy, effective January 9, 2026. Here's what billing teams need to know.
This update to NCD 268 Medicare policy covers two procedures: screening digital rectal examinations and screening prostate specific antigen (PSA) blood tests for early prostate cancer detection. The policy does not list specific CPT or HCPCS codes — your billing team will need to verify current code assignments through your MAC or CMS billing guidelines before submitting claims. The real risk here is frequency limit violations and provider qualification failures, both of which drive claim denial at high rates for preventive screening services.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Prostate Cancer Screening Tests |
| Policy Code | NCD 268 |
| Change Type | Modified |
| Effective Date | 2026-01-09 |
| Impact Level | Medium |
| Specialties Affected | Urology, Primary Care, Internal Medicine, Geriatrics, Nurse Practitioners, Physician Assistants, Clinical Nurse Specialists |
| Key Action | Audit your provider credentialing records and frequency tracking to confirm compliance with the once-every-12-months screening limit before billing. |
CMS Prostate Cancer Screening Coverage Criteria and Medical Necessity Requirements 2026
The CMS prostate cancer screening coverage policy under NCD 268 covers two distinct services. First, the screening digital rectal examination. Second, the screening PSA blood test. Both are covered for Medicare beneficiaries who meet the same core eligibility threshold: male, age 50 or older.
The medical necessity bar here is low by design — these are preventive screening services. Congress authorized this coverage under Section 4103 of the Balanced Budget Act of 1997. CMS doesn't require a clinical indication or a documented symptom to justify coverage. The beneficiary simply has to meet the age and frequency criteria.
Frequency limits are the billing team's primary compliance risk. Medicare covers each screening type once every 12 months. The policy uses precise language: at least 11 months must have passed following the month in which the last Medicare-covered screening was performed. This is not a calendar-year reset. Bill a PSA in March 2025 and the next covered PSA cannot be billed until March 2026 at the earliest — and technically not until the first date of the 12th subsequent month.
This distinction trips up billing teams who assume a January 1 reset. It doesn't work that way. Your practice management system needs to track the month of the last covered service, not just the calendar year.
NCD 268 does not address prior authorization requirements. Verify PA requirements with your MAC or payer contract before submitting claims. Frequency errors and provider qualification issues will be your most common obstacles.
Provider qualification rules are stricter than most billing teams realize. For the screening digital rectal examination, the exam must be performed — not just ordered — by a qualified provider. That means a doctor of medicine or osteopathy, or a physician assistant, nurse practitioner, clinical nurse specialist, or certified nurse midwife who meets three additional tests: authorized under State law to perform the exam, fully knowledgeable about the beneficiary's medical condition, and responsible for using the results in the overall management of the beneficiary's specific medical problem.
For the screening PSA test, the requirement shifts to the ordering provider rather than the performing provider. A qualified physician or mid-level practitioner must order the test. The same "fully knowledgeable" and "responsible for management" requirements apply. This is not a situation where any provider can drop in an order as a courtesy. The ordering provider must have a legitimate clinical relationship with the patient.
NCD 268 does not address cost-sharing. Consult CMS benefit policy guidelines and your MAC for applicable deductible and coinsurance rules for preventive screening services.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Screening digital rectal examination for early prostate cancer detection, men age 50+ | Covered | Not specified in NCD 268 — verify with your MAC | Once every 12 months; at least 11 months must have passed since last covered exam; must be performed by qualified provider |
| Screening PSA blood test for early detection of adenocarcinoma of prostate, men age 50+ | Covered | Not specified in NCD 268 — verify with your MAC | Once every 12 months; at least 11 months must have passed since last covered test; must be ordered by qualified provider with active management relationship |
| Screening digital rectal exam for men under age 50 | Not Covered | — | Does not meet age threshold |
| Screening PSA for men under age 50 | Not Covered | — | Does not meet age threshold |
| Screening digital rectal exam more frequently than once every 12 months | Not Covered | — | Frequency limit violation; second claim will deny |
| Screening PSA more frequently than once every 12 months | Not Covered | — | Frequency limit violation; second claim will deny |
CMS Prostate Cancer Screening Billing Guidelines and Action Items 2026
The effective date of January 9, 2026 means this policy is already in force. If you haven't reviewed your workflows against the updated NCD 268, do it now.
| # | Action Item |
|---|---|
| 1 | Verify your frequency tracking logic. Confirm your practice management system tracks the month and year of the last covered screening PSA and screening digital rectal exam — not just the calendar year. An 11-month minimum from the month of service must pass before the next covered screening. If your system resets on January 1 instead, you are generating frequency-related claim denials you could avoid. |
| 2 | Audit your provider credentialing against the qualification criteria. Pull the list of providers who order or perform these screenings in your practice. For digital rectal exams, confirm the performing provider meets state law authorization requirements and has a documented management relationship with the patient. For PSA orders, confirm the ordering provider qualifies under the §1861 definitions. Document this in your credentialing file. |
| 3 | Confirm cost-sharing rules with your MAC. NCD 268 does not address deductible or coinsurance requirements. Contact your MAC or review CMS benefit policy guidelines for the applicable cost-sharing rules for screening digital rectal examinations and screening PSA tests. Make sure your front desk communicates patient financial responsibility based on verified information — not assumptions. |
| 4 | Confirm current CPT and HCPCS codes with your MAC. NCD 268 does not list specific procedure codes in its policy text. Your Medicare Administrative Contractor publishes the applicable billing codes for these services. Contact your MAC or check their LCD and billing guidelines documentation to confirm you're using the correct codes before submitting claims under the updated policy. |
| 5 | Review claims from the past 12 months for frequency errors. Pull remittance data for any prostate cancer screening claim denial over the past year. If you're seeing frequency-related denials, trace them back to your tracking logic. Fix the root cause, not just the individual claim. |
| 6 | Train clinical staff on the "fully knowledgeable" requirement. This is not a checkbox. The ordering or performing provider must have genuine knowledge of the beneficiary's medical condition and must be responsible for acting on the results. If a locum or covering provider routinely drops these orders without patient contact, you have a medical necessity documentation problem. Talk to your compliance officer about your coverage policy for covering providers ordering preventive screenings. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Prostate Cancer Screening Under NCD 268
Covered Codes — Prostate Cancer Screening
NCD 268 does not specify CPT or HCPCS codes in its policy text. This is notable and worth flagging for your billing team. The absence of codes in the NCD itself means code assignment is handled at the MAC level through local billing guidelines.
| Code | Type | Description |
|---|---|---|
| Not specified in NCD 268 | — | Contact your Medicare Administrative Contractor for the applicable CPT and HCPCS codes for screening digital rectal examination and screening PSA tests |
A Note on Code Verification
Don't assume the codes you've been billing are still correct. Policy modifications like this one sometimes coincide with code assignment updates at the MAC level, even when the NCD text doesn't say so explicitly. Verify current codes with your MAC before billing under this updated policy.
Your MAC's website will have Local Coverage Determinations and billing articles that list the specific codes. Search for prostate cancer screening or the relevant CPT family. If you're not sure which MAC covers your jurisdiction, CMS maintains a MAC jurisdiction map on its website.
Key ICD-10-CM Diagnosis Codes
NCD 268 does not specify ICD-10-CM codes. For screening services, the appropriate Z-code for encounter for screening will typically apply. Confirm the correct diagnosis code for screening digital rectal examination and screening PSA with your MAC's billing documentation.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.